The certification follows Scopio’s recent IVDR approval for its Full-Field Peripheral Blood Smear (FF-PBS) Application with RBC AI-powered decision support, establishing a unified, regulated digital workflow for hematology labs across the European Union.

The Full-Field Advantage: Cells Always in Context

Bone marrow analysis is a notoriously labor-intensive and manual process, requiring experts to choose between wide-area context at low power and cellular detail at high power. Scopio’s proprietary Full-Field imaging technology eliminates this trade-off, capturing large areas of the slide in one continuous digital view at 100x oil-immersion equivalent resolution. This makes Scopio the only provider of a consecutive digital copy of the patient sample, preserving the holistic view necessary for complex bone marrow assessment.